The industry’s robotics market showed the strongest sector growth in the second quarter of 2025, according to new data from the Association for Advancing Automation.
The investment is part of the drugmaker’s previously announced plan to invest more than $10 billion in its U.S. manufacturing operations over the next 10 years.
